,,ii  #aagth ,,congress  #ast ,session  
,s4 #ccbg  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,december #g1  
#bjba ,mr4 ,markey 7for himself1 ,mr4   
,manchin1 ,mr4 ,brown1 and ,mr4 ,durbin7
 introduced the following bill2 which   
was read twice and referred to the      
,committee on the ,judiciary  ,a ,,bill 
,to amend the ,controlled ,substances   
,act to require the ,attorney ,general  
to make procurement quotas for opioid   
analgesics publicly available1 and for  
other purposes4  #a4 ,short title ,this 
,act may be cited as the ,opioid ,quota 
,openness1 ,transparency1 and ,awareness
 ,act of #bjba or the ,opioid ,qu,o,t,a 
,act of #bjba4  #b4 ,public reporting of
 procurement quotas for opioid          
analgesics  7a7 ,in general ,section    
#cjf of the ,controlled ,substances ,act
 7#ba ,u4,s4,c4 #hbf7 is amended by     
adding at the end the following3  7j7   
7#a7 ,in this subsection1 the term      
opioid procurement quota means a quota  
established by the ,attorney ,general   

for the quantity of opioid analgesics   
that a registered manufacturer may      
procure for purposes of manufacturing   
dosage forms or other substances4  7#b7 
,the ,attorney ,general shall make      
publicly available1 including through   
the website of the ,drug ,enforcement   
,administration--  7,a7 the quantity of 
the opioid procurement quota for each   
registered manufacturer for each year2  
7,b7 the quantity of opioid analgesics  
procured by each registered manufacturer
 for each year2 and  7,c7 except as     
provided under paragraph 7#c7-- 7i7 a   
copy of the form or other application1  
including any attachments or exhibits1  
submitted by each registered            
manufacturer requesting an opioid       
procurement quota2 and  7ii7 a copy of  
each year-end or annual report relating 
to the procurement or use of opioid     
analgesics submitted to the ,attorney   
,general by a registered manufacturer to
 whom the ,attorney ,general has issued 
an opioid procurement quota4  7#c7 7,a7 

,upon request by a registered           
manufacturer1 the ,attorney ,general may
 redact information identified in clause
 7i7 or 7ii7 of paragraph 7#b77;,c7 from
 the publication required under         
paragraph 7#b7 if the ,attorney ,general
 determines that public disclosure of   
that information is likely to cause     
substantial harm to the competitive     
position of the registered manufacturer4
 ,for purposes of a determination under 
this subparagraph1 adverse publicity or 
embarrassment shall not constitute      
competitive harm4  7,b7 ,a determination
 of the ,attorney ,general under        
subparagraph 7,a7 shall be subject to   
judicial review in accordance with      
chapter #g of title #e1 ,united ,states 
,code4  7,c7 ,the ,attorney ,general    
shall annually publish a report on the  
website of the ,department of ,justice  
containing an accounting of each        
declination determination made under    
subparagraph 7,a71 including the reason 
for the declination1 during the time    

period covered by the report4  4  7b7   
,,gao report ,the ,comptroller ,general 
of the ,united ,states shall submit to  
,congress a report that1 for the #a-year
 period beginning on the date of        
enactment of this ,act-- 7#a7 details-- 
7,a7 the number of instances in which a 
registered manufacturer made a request  
described in section #cjf7;j77#c7 of the
 ,controlled ,substances ,act1 as added 
by subsection 7a71 with respect to a    
document or information2 and  7,b7 the  
number of instances in which the        
,attorney ,general redacted information 
described in clause 7i7 or 7ii7 of      
subsection 7j77#b77;,c7 of the          
,controlled ,substances ,act1 as added  
by subsection 7a71 from the publication 
required under such subsection 7j77#b72 
and  7#b7 evaluates1 in a fair1         
compliant1 and transparent manner1 the  
extent of the independent evaluation    
conducted by the ,attorney ,general of  
requests described in section           
#cjf7;j77#c7 of the ,controlled         

,substances ,act1 as added by subsection
 7a74